Vision Researchers Query FDA About Updating Requirements For Drug Approval
Scientists and the Food and Drug Administration (FDA) are discussing how new technologies in ophthalmology, which make it possible to collect better data about experimental treatments, might affect FDA clinical trials requirements.
Read Full Article
Related Articles
- Dynamic OCT measurement of corneal deformation by an air puff in normal and cross-linked corneas also categorized in Ophthalmology
- Successful OCT Imaging Of Oral Cancer Tissue Announced By MDL And UCH, UK also published in Medical News Today
- Corneal biometry from volumetric SDOCT and comparison with existing clinical modalities also categorized in Ophthalmology
- Automated phase retardation oriented segmentation of chorio-scleral interface by polarization sensitive optical coherence tomography also categorized in Ophthalmology
- Passive component based multifunctional Jones matrix swept source optical coherence tomography for Doppler and polarization imaging also categorized in Ophthalmology
- Impact of intraocular pressure on changes of blood flow in the retina, choroid, and optic nerve head in rats investigated by optical microangiography also categorized in Ophthalmology
- Automated segmentation of retinal blood vessels in spectral domain optical coherence tomography scans also categorized in Ophthalmology
- Spectral-domain OCT with dual illumination and interlaced detection for simultaneous anterior segment and retina imaging also categorized in Ophthalmology
- Medical Imaging Embedded Systems Expertise Expands, UK also published in Medical News Today
- Extended depth of focus adaptive optics spectral domain optical coherence tomography also categorized in Ophthalmology
Login to comment.